Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04628780
Title Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Investigational Drug Service (IDS) Duarte California 91010 United States Details
City of Hope Duarte California 91010 United States Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095 United States Details
UCLA Hematology/Oncology Los Angeles California 90095 United States Details
Santa Monica UCLA Medical Center & Orthopaedic Hospital Santa Monica California 90404 United States Details
UCLA Hematology Oncology - Santa Monica Santa Monica California 90404 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
The Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee 37203 United States Details
TriStar Centennial Medical Center Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center- Investigational Pharmacy Houston Texas 77030 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Christus Santa Rosa Hospital San Antonio Texas 78229 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field